⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LPCN News
Lipocine Inc.
Lupin Announces the Approval of Dapagliflozin Tablets in the United States
prnewswire.com
LPCN
Lipocine Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
globenewswire.com
LPCN
Form 8-K
sec.gov
LPCN
Form 8-K
sec.gov
LPCN
Lipocine Reports Topline Safety and Efficacy Results for LPCN 1154 in Patients with Postpartum Depression
prnewswire.com
LPCN
Lipocine Announces Financial Results for the Full Year Ended December 31, 2025
prnewswire.com
LPCN
Form 8-K
sec.gov
LPCN
Form 8-K
sec.gov
LPCN
New to The Street and Wall Street New York Magazine Launch Weekly Executive Publication with Integrated NewsOut Video Press Distribution
accessnewswire.com
VRTX
NRXP
ONCO
LPCN
RDZN
BIVI
Lipocine Announces Last Patient Last Visit in Pivotal Phase 3 Trial of LPCN 1154 for Postpartum Depression (PPD)
prnewswire.com
LPCN